Literature DB >> 30618207

Receptor activity-modifying protein 1 regulates the phenotypic expression of BMSCs via the Hippo/Yap pathway.

Qin Zhang1,2, Yanjun Guo1,2, Hui Yu1,2, Yufei Tang1,2, Ying Yuan1,2, Yixuan Jiang1,2, Huilu Chen1,2, Ping Gong1,2, Lin Xiang1,2.   

Abstract

Receptor activity-modifying protein 1 (RAMP1) might be a critical regulator during bone wound healing. However, the roles and mechanisms of RAMP1 in osteogenesis remain unclear. Here, we aimed to elucidate the role of RAMP1 and explore the effects of Yes-associated protein 1 (Yap1), an effector of the Hippo/Yap pathway, in this process. We used a RAMP1 overexpression lentiviral system in bone marrow mesenchymal stem cells (BMSCs), which enhanced RAMP1 expression in an effective, appropriate, and sustained manner. Alkaline phosphatase (ALP) activity assays and alizarin red staining showed that RAMP1 promoted osteogenic differentiation of BMSCs after calcitonin gene-related peptide (CGRP) treatment (10 -8  mol/L). Moreover, real-time polymerase chain reaction and Western blot analysis indicated that RAMP1 upregulated the expression of osteogenic phenotypic markers (ALP, runt-related transcription factor 2, osteopontin; p < 0.05). To further uncover the mechanism of RAMP1 in osteogenic differentiation, we used verteporfin (10 -7  mol/L) to block Yap1. Notably, verteporfin impaired RAMP1-induced osteogenesis. Taken together, our findings confirmed that RAMP1 is a key mediator of bone regeneration and indicate that RAMP1 promotes CGRP-induced osteogenic differentiation of BMSCs via regulation of the Hippo/Yap pathway.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  osteogenesis; receptor activity-modifying protein 1; yes-associated protein 1

Mesh:

Substances:

Year:  2019        PMID: 30618207     DOI: 10.1002/jcp.28082

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.

Authors:  Marwa Alhothali; Mevin Mathew; Geeta Iyer; Harshani R Lawrence; Shengyu Yang; Srikumar Chellappan; Jaya Padmanabhan
Journal:  Int J Mol Sci       Date:  2019-05-16       Impact factor: 5.923

2.  Neuromodulation of bone: Role of different peptides and their interactions (Review).

Authors:  Xiaoyu Wang; Jia Xu; Qinglin Kang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

Review 3.  CGRP: A New Endogenous Cell Stemness Maintenance Molecule.

Authors:  Xiaoting Lv; Qingquan Chen; Shuyu Zhang; Feng Gao; Qicai Liu
Journal:  Oxid Med Cell Longev       Date:  2022-01-29       Impact factor: 6.543

4.  Epigallocatechin gallate attenuates tumor necrosis factor (TNF)-α-induced inhibition of osteoblastic differentiation by up-regulating lncRNA TUG1 in osteoporosis.

Authors:  Yanfeng Han; Dening Pei; Wenjing Li; Bin Luo; Qingsong Jiang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 5.  Exploring the effect of the "quaternary regulation" theory of "peripheral nerve-angiogenesis-osteoclast-osteogenesis" on osteoporosis based on neuropeptides.

Authors:  Shuhua Liu; Tongying Chen; Ruolin Wang; Hongxing Huang; Sai Fu; Yu Zhao; Shihao Wang; Lei Wan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

6.  Characterization of Perturbing Actions by Verteporfin, a Benzoporphyrin Photosensitizer, on Membrane Ionic Currents.

Authors:  Mei-Han Huang; Ping-Yen Liu; Sheng-Nan Wu
Journal:  Front Chem       Date:  2019-08-22       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.